A study found encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial participants… Read more »
Tag: Daniel Adelman
Panel Backs FDA Approval for Aimmune’s Peanut OIT Drug
An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »